Results 91 to 100 of about 304,767 (203)
Altered protein expression in serum from endometrial hyperplasia and carcinoma patients
Background Endometrial carcinoma is one of the most common gynecological malignancies in women. The diagnosis of the disease at early or premalignant stages is crucial for the patient's prognosis. To date, diagnosis and follow-up of endometrial carcinoma
Cong Qing +7 more
doaj +1 more source
CEBPB promotes transformation of endometrial complex atypical hyperplasia to endometrial cancer
As the precursor malignancy of endometrial cancer (EC), about 50% of endometrial complex atypical hyperplasia (CAH) will eventually progress to EC. Elucidating the underlying transformation mechanisms could aid in disease management.EC, CAH, reversed CAH and normal endometrium tissues were collected and sequenced to identify genes involved in the ...
Jiahong Tan +9 more
openaire +3 more sources
Baseline characteristics of patients who were diagnosed with non-atypical or atypical endometrial hyperplasia during 2020.
Ian Henderson (1634368) +4 more
core +1 more source
The article presents the results of organ-preserving treatment protocol of atypical endometrial hyperplasia and well-differentiated endometrial carcinoma in young women. This protocol was applied in 24 patients. The period of patients observation was 3—6
A. I. Pashov, V. B. Tskhai, E. N. Sivova
doaj
Objective: To evaluate the patients diagnosed with atypical endometrial hyperplasia preoperatively, and compare preoperative and postoperative results.
Besler, A. +13 more
core
Telomeres and telomerase in endometrial cancer and hyperplasia
Introduction The study aimed to measure telomeres length (TL) and telomerase expression in normal endometrium and endometrial hyperplasia and cancer. Material and methods Total RNA and DNA were isolated from endometrium samples of 117 patients.
Anna Pańczyszyn +4 more
core +1 more source
Atypical hyperplasia of the endometrium is a precancerous condition for endometrioid adenocarcinoma of the endometrium, which is the largest group among malignant neoplasms of the uterine body, according to the Cancer Registry, the mortality rate from ...
P. V. Savchenko +3 more
doaj +1 more source
IntroductionThe purpose of this study was to determine whether aberrant expression of the von Hippel-Lindau (VHL) gene in human hyperplastic and malignant endometrial tissues was involved in endometrial carcinogenesis.MethodsFresh tissue samples of ...
Xiao-Zhe Cao +4 more
core +1 more source
Molecular markers in endometrial hyperplasia
Endometrial hyperplasias show most of the molecular changes observed in endometrial carcinomas. PTH-rp, a growth factor, and LIF, a cytokine are over-expressed in endometrial hyperplasias, particularly in the complex atypical hyperplasia group.
Bozdoğan, Önder, Atasoy, Pınar
core
Maspin expression, subcellular localization and clinicopathological correlation in endometrial hyperplasia and endometrial adenocarcinoma. [PDF]
Maspin expression in endometrial hyperplasia and endometrial endometrioid adeno-carcinomas was assessed and its correlation with p53 and Ki-67 expressions and clinical outcome, as well as its potential to distinguish typical from atypical endometrial ...
BLANDAMURA, STELLA +11 more
core

